Search

Disease Prevalence and Treatment Reticence

Reaching and Helping Lost Patients

Direct-to-Consumer Advertising Continues To Trigger Consumer Action

Vioxx Recall Had Minor Impact On The Effectiveness Of DTCA, According To Latest PharmTrends Research

Is Direct To Consumer Advertising Putting More Americans At Risk?

Despite The Recent Heavy Scrutiny, Consumers Continue To Support Rx Advertising, According To The Latest Ipsos Survey

Less than Half of Americans Treat New Conditions with Prescription

Almost as many buy nothing in the year after a new diagnosis, according to Ipsos-Insight PharmTrends

Ipsos Ideas: Vioxx Recall Hurt American's Confidence In FDA, Not Prescription Drugs

Consumers Understand Trade-Offs Between Drug Benefit And Risks, According To Ipsos survey

Living Longer, Living Stronger

The Health Challenge of an Aging Population

Dr. Jekyll and Mr. Hyde: Pharmaceutical Companies Contend with Drug Benefit and Risk Communications

AP/Ipsos Poll: Americans Mostly Confident Prescription Drugs Are Safe

One In Five Americans Has Driven After Drinking In Past Year, Says New Findlaw Survey

The Long Road Ahead For DTC Advertising

Stagnant Levels Of Doctor Contact Rates Continue And May Take A Turn For The Worse Following Vioxx Withdrawal, Says The Latest Update From Ipsos PharmTrends174